HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tsutomu Takeuchi Selected Research

Rheumatoid Arthritis

2/2016Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
1/2016The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
1/2016Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.
11/2015Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis.
10/2015The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo/active-controlled, dose-ranging study.
10/2015Infliximab and etanercept have distinct actions but similar effects on cytokine profiles in rheumatoid arthritis.
10/2015Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
9/2015Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders.
7/2015Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan.
7/2015Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Tsutomu Takeuchi Research Topics

Disease

107Rheumatoid Arthritis
02/2016 - 06/2004
24Infection
07/2015 - 12/2002
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 09/2003
9Cysts
06/2012 - 09/2002
7Inflammation
05/2015 - 06/2004
7Interstitial Lung Diseases (Interstitial Lung Disease)
01/2014 - 09/2005
6Pneumonia (Pneumonitis)
11/2012 - 01/2007
5Drug Toxicity (Drug Safety)
01/2016 - 11/2010
5Rheumatic Diseases (Rheumatism)
10/2011 - 01/2007
4Pain (Aches)
01/2015 - 05/2012
4Fever (Fevers)
01/2015 - 09/2005
4Autoimmune Diseases (Autoimmune Disease)
01/2013 - 08/2005
3Lupus Nephritis
01/2016 - 01/2007
3Ulcer
02/2015 - 05/2012
3Lung Diseases (Lung Disease)
01/2015 - 11/2012
3Connective Tissue Diseases (Connective Tissue Disease)
11/2013 - 10/2012
3Amebiasis (Amoebiasis)
03/2004 - 08/2003
2Sjogren's Syndrome (Sjogren Syndrome)
02/2016 - 08/2008
2Arthritis (Polyarthritis)
05/2015 - 01/2006
2Adult-Onset Still's Disease
05/2015 - 03/2012
2Mixed Connective Tissue Disease (MCTD)
02/2015 - 10/2012
2Systemic Scleroderma (Systemic Sclerosis)
02/2015 - 01/2007
2Acute Kidney Injury (Acute Renal Failure)
01/2015 - 01/2011
2Myositis (Idiopathic Inflammatory Myopathies)
01/2014 - 09/2005
2Acute Disease
01/2014 - 06/2005
2Body Weight (Weight, Body)
01/2014 - 01/2008
2Osteoarthritis
01/2013 - 05/2012
2Opportunistic Infections (Opportunistic Infection)
11/2012 - 01/2005
2Arthralgia (Joint Pain)
03/2012 - 07/2011
2Acquired Immunodeficiency Syndrome (AIDS)
07/2010 - 01/2008
2Amebic Dysentery (Amoebic Dysentery)
01/2010 - 05/2008
2Amebic Liver Abscess
01/2010 - 05/2008
2Lung Injury
10/2009 - 01/2008
2Communicable Diseases (Infectious Diseases)
03/2009 - 10/2003
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2008 - 01/2007
2Tuberculosis (Tuberculoses)
01/2007 - 01/2005
2Colitis
04/2005 - 08/2003
2Chagas Disease (American Trypanosomiasis)
06/2003 - 03/2003
1Synovitis
02/2016
1Experimental Arthritis
05/2015
1Abdominal Pain (Pain, Abdominal)
01/2015

Drug/Important Bio-Agent (IBA)

30Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 12/2004
24infliximab (Remicade)FDA Link
11/2015 - 01/2005
19tocilizumabFDA Link
10/2015 - 09/2007
15TNFR-Fc fusion protein (etanercept)FDA Link
10/2015 - 12/2002
14Interleukin-6 (Interleukin 6)IBA
01/2016 - 06/2004
12Antirheumatic Agents (DMARD)IBA
07/2015 - 01/2006
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 01/2005
8adalimumab (Humira)FDA Link
07/2015 - 06/2012
7Biological Markers (Surrogate Marker)IBA
02/2016 - 01/2009
7abatacept (BELATACEPT)FDA Link
09/2015 - 03/2013
7GlucocorticoidsIBA
01/2015 - 02/2003
7Prednisolone (Predate)FDA LinkGeneric
01/2015 - 09/2005
6CDP870FDA Link
01/2016 - 07/2014
6CytokinesIBA
10/2015 - 09/2005
6Messenger RNA (mRNA)IBA
06/2012 - 09/2003
5AntibodiesIBA
01/2015 - 02/2003
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 09/2005
5Tacrolimus (Prograf)FDA LinkGeneric
01/2014 - 02/2009
4C-Reactive ProteinIBA
05/2015 - 01/2008
4Idiopathic pulmonary hypertensionIBA
02/2015 - 01/2007
4Carbon MonoxideIBA
07/2014 - 12/2010
4AntigensIBA
04/2012 - 03/2004
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2007 - 06/2005
4zeta chain antigen T cell receptor (TCR zeta chain)IBA
08/2005 - 09/2003
3beta-cyclodextrin tetradecasulfate (CTDS)IBA
02/2015 - 10/2012
3AutoantibodiesIBA
01/2014 - 01/2011
3leflunomide (Arava)FDA LinkGeneric
10/2009 - 01/2008
3DNA (Deoxyribonucleic Acid)IBA
09/2007 - 06/2003
2rituximab (Mabthera)FDA Link
01/2016 - 01/2007
2bucillamine (SA 96)IBA
10/2013 - 01/2006
2golimumabFDA Link
09/2013 - 06/2012
2EnzymesIBA
01/2013 - 10/2009
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2013 - 07/2011
2Immunoglobulin G (IgG)IBA
04/2012 - 01/2005
2Ferritins (Ferritin)IBA
03/2012 - 01/2002
2Interleukin-2 (IL2)IBA
01/2011 - 03/2005
2ametantrone (HAQ)IBA
08/2010 - 01/2009
2GelatinIBA
10/2009 - 01/2005
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2008 - 04/2005
23' Untranslated Regions (3' UTR)IBA
03/2008 - 01/2006
2polyglucosanIBA
01/2008 - 04/2007
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2007 - 09/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007 - 09/2005
2Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
04/2005 - 08/2003
2Recombinases (Recombinase)IBA
04/2005 - 08/2003
2T-Cell Antigen Receptor-CD3 ComplexIBA
03/2005 - 09/2003
1Interleukin-16 (Interleukin 16)IBA
02/2016
1N 30IBA
02/2016
1ChemokinesIBA
11/2015
1Leucine (L-Leucine)FDA Link
05/2015
1Glycoproteins (Glycoprotein)IBA
05/2015
1PTX3 proteinIBA
02/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2015
1erucylphosphocholineIBA
02/2015
1OsteopontinIBA
01/2015

Therapy/Procedure

4Biological Therapy
05/2015 - 11/2010
2Aftercare (After-Treatment)
05/2015 - 01/2011
2Artificial Respiration (Mechanical Ventilation)
10/2009 - 01/2008
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2007 - 10/2002